Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bausch & Lomb Corp (BLCO) Cash Flow Statement

Bausch & Lomb Corp (BLCO) generated $458.0M of operating cash flow over the twelve months to 2026-06-30, spent $321.0M on capital expenditure and had free cash flow of $137.0M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BLCOBausch & Lomb CorpFollow BLCO — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
6.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow0.35-0.020.230.280.46
Capital expenditure0.180.180.290.35-0.32
Free cash flow0.17-0.20-0.06-0.070.14
Stock-based compensation0.060.070.090.15—

USD billions · SEC XBRL

Bausch & Lomb Corp — questions

What is Bausch & Lomb Corp's operating cash flow?
$458.0M over the twelve months to 2026-06-30.
How much does Bausch & Lomb Corp spend on capital expenditure?
$321.0M over the twelve months to 2026-06-30.
What is Bausch & Lomb Corp's free cash flow?
$137.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Bausch & Lomb Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.